These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20938199)

  • 1. The impact of rate reduction and increased loudness on fundamental frequency characteristics in dysarthria.
    Tjaden K; Wilding G
    Folia Phoniatr Logop; 2011; 63(4):178-86. PubMed ID: 20938199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rate reduction and increased loudness on acoustic measures of anticipatory coarticulation in multiple sclerosis and Parkinson's disease.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2005 Apr; 48(2):261-77. PubMed ID: 15989391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions.
    Tjaden K; Lam J; Wilding G
    J Speech Lang Hear Res; 2013 Oct; 56(5):1485-502. PubMed ID: 23838989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Speaking Rate on Variability of Second Formant Frequency Transitions in Dysarthria.
    van Brenk F; Lowit A; Tjaden K
    Folia Phoniatr Logop; 2024; 76(3):295-308. PubMed ID: 37769645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.
    Kuo C; Tjaden K; Sussman JE
    J Commun Disord; 2014; 52():156-69. PubMed ID: 25287378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
    Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
    Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consonant Acoustics in Parkinson's Disease and Multiple Sclerosis: Comparison of Clear and Loud Speaking Conditions.
    Tjaden K; Martel-Sauvageau V
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):569-582. PubMed ID: 28654940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breath-group intelligibility in dysarthria: characteristics and underlying correlates.
    Yunusova Y; Weismer G; Kent RD; Rusche NM
    J Speech Lang Hear Res; 2005 Dec; 48(6):1294-310. PubMed ID: 16478372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between acoustic measures and judgments of intelligibility in Parkinson's disease: a within-speaker approach.
    Feenaughty L; Tjaden K; Sussman J
    Clin Linguist Phon; 2014 Nov; 28(11):857-78. PubMed ID: 24874184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of interutterance stability: application to dysarthria.
    Cummins F; Lowit A; van Brenk F
    J Speech Lang Hear Res; 2014 Feb; 57(1):81-9. PubMed ID: 24687469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between acoustic measures and speech naturalness ratings in Parkinson's disease: A within-speaker approach.
    Klopfenstein M
    Clin Linguist Phon; 2015; 29(12):938-54. PubMed ID: 26403503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech and pause characteristics associated with voluntary rate reduction in Parkinson's disease and Multiple Sclerosis.
    Tjaden K; Wilding G
    J Commun Disord; 2011; 44(6):655-65. PubMed ID: 21767851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentence-Level Movements in Parkinson's Disease: Loud, Clear, and Slow Speech.
    Kearney E; Giles R; Haworth B; Faloutsos P; Baljko M; Yunusova Y
    J Speech Lang Hear Res; 2017 Dec; 60(12):3426-3440. PubMed ID: 29209727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticipatory coarticulation in multiple sclerosis and Parkinson's disease.
    Tjaden K
    J Speech Lang Hear Res; 2003 Aug; 46(4):990-1008. PubMed ID: 12959475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parkinsonian dysarthria].
    Gentil M; Pollak P; Perret J
    Rev Neurol (Paris); 1995 Feb; 151(2):105-12. PubMed ID: 7676137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.